Total

Germany

France

UK

Spain

Poland

BASE: total respondents

1513

301

304

300

308

300

Application time (Frequency/Percentage)

Morning

504

33.3%

109

36.2%

142

46.7%

82

27.3%

53

17.2%

118

39.3%

Afternoon

328

21.7%

56

18.6%

78

25.7%

56

18.7%

45

14.6%

93

31.0%

Evening

1,347

89.0%

272

90.4%

265

87.2%

279

93.0%

284

92.2%

247

82.3%

Method of administration (Frequency/Percentage)

Topical/External

1055

69.7%

197

65.4%

167

54.9%

181

60.3%

218

70.8%

292

97.3%

Inhalation

131

8.7%

25

8.3%

45

14.8%

35

11.7%

26

8.4%

0

0.0%

Both topical and inhalation

319

21.1%

79

26.2%

92

30.3%

84

28.0%

64

20.8%

0

0.0%

Other

8

0.5%

0

0.0%

0

0.0%

0

0.0%

0

0.0%

8

2.7%

Day of disease when VVR was used (Frequency/Percentage)

Day 1 - 2

706

46.7%

167

55.5%

48

15.8%

150

50.0%

146

47.4%

195

65.0%

Day 3 - 4

1,136

75.1%

237

78.7%

212

69.7%

239

79.7%

222

72.1%

226

75.3%

Day 5 - 6

394

26.0%

97

32.2%

55

18.1%

102

34.0%

54

17.5%

86

28.7%